Literature DB >> 10766399

Urinary excretion of aquaporin-2 in pathological states of water metabolism.

S Ishikawa.   

Abstract

Aquaporin-2 (AQP-2) is an arginine vasopressin (AVP)-regulated water channel in renal collecting duct cells. Approximately 3 % of AQP-2 in collecting duct cells is excreted into urine. Urinary excretion of AQP-2 varies widely in different physiological conditions, and it has a positive correlation with plasma AVP levels. Urinary excretion of AQP-2 was significantly increased by the single injection of AVP in patients with central diabetes insipidus. The urinary excretion of AQP-2 was one-eighth over in patients with central diabetes insipidus and three times greater in patients with impaired water excretion than that in normal subjects. In a hypertonic saline test, the urinary excretion of AQP-2 promptly increased 6-12-fold in normal subjects, but remained low in patients with central diabetes insipidus. In addition, exaggerated urinary excretion of AQP-2 persisted after an acute water load in patients with impaired water excretion. These results indicate that urinary excretion of AQP-2 is a potent marker for the diagnosis of water metabolism disorders dependent on AVP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10766399     DOI: 10.3109/07853890009011757

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  9 in total

Review 1.  Aquaporins: translating bench research to human disease.

Authors:  A S Verkman
Journal:  J Exp Biol       Date:  2009-06       Impact factor: 3.312

2.  Renal phenotype in Bardet-Biedl syndrome: a combined defect of urinary concentration and dilution is associated with defective urinary AQP2 and UMOD excretion.

Authors:  Miriam Zacchia; Enza Zacchia; Enrica Zona; Giovanna Capolongo; Ilaria Raiola; Luca Rinaldi; Francesco Trepiccione; Diego Ingrosso; Alessandra Perna; Valentina Di Iorio; Francesca Simonelli; Orson W Moe; Giovambattista Capasso
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-03

Review 3.  Aquaporins in clinical medicine.

Authors:  A S Verkman
Journal:  Annu Rev Med       Date:  2012       Impact factor: 13.739

4.  Urinary aquaporin-2 excretion during early human development.

Authors:  Marina Zelenina; Yanhong Li; Isabelle Glorieux; Catherine Arnaud; Christelle Cristini; Stéphane Decramer; Anita Aperia; Charlotte Casper
Journal:  Pediatr Nephrol       Date:  2006-06-01       Impact factor: 3.714

Review 5.  Aquaporins in lung health and disease: Emerging roles, regulation, and clinical implications.

Authors:  Ekta Yadav; Niket Yadav; Ariel Hus; Jagjit S Yadav
Journal:  Respir Med       Date:  2020-10-17       Impact factor: 3.415

6.  Common sense approaches to urinary biomarker study design.

Authors:  Mark A Knepper
Journal:  J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 10.121

Review 7.  The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases.

Authors:  Tanja Vukićević; Maike Schulz; Dörte Faust; Enno Klussmann
Journal:  Front Pharmacol       Date:  2016-02-11       Impact factor: 5.810

8.  Breviscapine prevents downregulation of renal water and sodium transport proteins in response to unilateral ureteral obstruction.

Authors:  Yang Mei; Zhuang Yangyang; Luo Shuai; Jin Hao; Yang Yirong; Cai Yong; Xia Peng; Chen Bicheng; Zhang Yan
Journal:  Iran J Basic Med Sci       Date:  2016-05       Impact factor: 2.699

9.  Detection of renal tissue and urinary tract proteins in the human urine after space flight.

Authors:  Lyudmila Kh Pastushkova; Kirill S Kireev; Alexey S Kononikhin; Evgeny S Tiys; Igor A Popov; Natalia L Starodubtseva; Igor V Dobrokhotov; Vladimir A Ivanisenko; Irina M Larina; Nicolay A Kolchanov; Evgeny N Nikolaev
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.